CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
Table 1
Descriptive Statistics. This table shows clinicopathologic characteristics of the study participants including demographic information, tumor characteristics, and survival data.